(Q51780619)

12 April 2018

title

Gastroenterologists' prescribing of infliximab for Crohn's disease: a national survey. (English)

1 reference

12 April 2018

1 reference

1 reference

Meaghan St Charles

1

1 reference

12 April 2018

Sheila R Weiss Smith

2

1 reference

12 April 2018

Robert Beardsley

3

1 reference

12 April 2018

Donald O Fedder

4

1 reference

12 April 2018

Olivia Carter-Pokras

5

1 reference

12 April 2018

Raymond K Cross

6

1 reference

12 April 2018

publication date

1 October 2009

1 reference

12 April 2018

Inflammatory Bowel Diseases

published in

1 reference

12 April 2018

volume

15

1 reference

12 April 2018

issue

10

1 reference

12 April 2018

page(s)

1467-1475

1 reference

12 April 2018

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

cites work

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

Infliximab maintenance therapy for fistulizing Crohn's disease

21 January 2018

1 reference

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

21 January 2018

1 reference

Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program

21 January 2018

1 reference

Prescribing patterns and awareness of adverse effects of infliximab: a health survey of gastroenterologists

21 January 2018

1 reference

Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

Age, specialty, and practice setting predict gastroesophageal reflux disease prescribing behavior

21 January 2018

1 reference

Are patients with inflammatory bowel disease receiving optimal care?

21 January 2018

1 reference

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

21 January 2018

1 reference

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

21 January 2018

1 reference

Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial

21 January 2018

1 reference

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

21 January 2018

1 reference

Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test

21 January 2018

1 reference

Methodologies for improving response rates in surveys of physicians: a systematic review

21 January 2018

1 reference

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.20904

1 reference

12 April 2018

1 reference

12 April 2018